Document Classification

Section Type: RESULTS

Text: Progestogen-treated neonates had a significantly lower composite neonatal morbidity (19. 1 %) compared with placebo (30. 9 %) (odds ratio, OR 0. 53 ; 95 % CI 0. 31-0. 90 ; P = 0. 02), with significantly lower odds for respiratory distress syndrome (14. 4 versus 23. 4 % ; OR 0. 55 ; 95 % CI 0. 31-0. 98 ; P = 0. 04), retinopathy of prematurity (1. 1 versus 4. 6 % ; OR 0. 21 ; 95 % CI 0. 05-0. 96 ; P = 0. 04), and culture-confirmed sepsis (3. 4 versus 12. 8 % ; OR 0. 24 ; 95 % CI 0. 10-0. 57 ; P = 0. 00).